365 related articles for article (PubMed ID: 8176895)
1. Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides.
Maury CP; Nurmiaho-Lassila EL; Rossi H
Lab Invest; 1994 Apr; 70(4):558-64. PubMed ID: 8176895
[TBL] [Abstract][Full Text] [Related]
2. Fibrillogenesis in gelsolin-related familial amyloidosis.
Maury CP; Nurmiaho-Lassila EL; Boysen G; Liljeström M
Amyloid; 2003 Aug; 10 Suppl 1():21-5. PubMed ID: 14640038
[TBL] [Abstract][Full Text] [Related]
3. Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin.
Maury CP
J Clin Invest; 1991 Apr; 87(4):1195-9. PubMed ID: 1849145
[TBL] [Abstract][Full Text] [Related]
4. The amyloidogenicity of gelsolin is controlled by proteolysis and pH.
Ratnaswamy G; Koepf E; Bekele H; Yin H; Kelly JW
Chem Biol; 1999 May; 6(5):293-304. PubMed ID: 10322122
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease-associated presenilins 1 and 2: accelerated amyloid fibril formation of mutant 410 Cys-->Tyr and 141 Asn-->Ile peptides.
Maury CP; Nurmiaho-Lassila EL; Liljeström M
Biochem Biophys Res Commun; 1997 Jun; 235(1):249-52. PubMed ID: 9196071
[TBL] [Abstract][Full Text] [Related]
6. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187.
de la Chapelle A; Tolvanen R; Boysen G; Santavy J; Bleeker-Wagemakers L; Maury CP; Kere J
Nat Genet; 1992 Oct; 2(2):157-60. PubMed ID: 1338910
[TBL] [Abstract][Full Text] [Related]
7. Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation.
Orpiszewski J; Benson MD
J Mol Biol; 1999 Jun; 289(2):413-28. PubMed ID: 10366514
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides.
Maury CP
Lab Invest; 1991 Mar; 64(3):400-4. PubMed ID: 1848334
[TBL] [Abstract][Full Text] [Related]
9. Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type).
Maury CP; Liljeström M; Boysen G; Törnroth T; de la Chapelle A; Nurmiaho-Lassila EL
J Clin Pathol; 2000 Feb; 53(2):95-9. PubMed ID: 10767822
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
11. Identification of the circulating amyloid precursor and other gelsolin metabolites in patients with G654A mutation in the gelsolin gene (Finnish familial amyloidosis): pathogenetic and diagnostic implications.
Maury CP; Sletten K; Totty N; Kangas H; Liljeström M
Lab Invest; 1997 Oct; 77(4):299-304. PubMed ID: 9354764
[TBL] [Abstract][Full Text] [Related]
12. Creation of amyloid fibrils from mutant Asn187 gelsolin peptides.
Maury CP; Nurmiaho-Lassila EL
Biochem Biophys Res Commun; 1992 Feb; 183(1):227-31. PubMed ID: 1311922
[TBL] [Abstract][Full Text] [Related]
13. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.
Morozova-Roche LA; Zurdo J; Spencer A; Noppe W; Receveur V; Archer DB; Joniau M; Dobson CM
J Struct Biol; 2000 Jun; 130(2-3):339-51. PubMed ID: 10940237
[TBL] [Abstract][Full Text] [Related]
14. Loss of a metal-binding site in gelsolin leads to familial amyloidosis-Finnish type.
Kazmirski SL; Isaacson RL; An C; Buckle A; Johnson CM; Daggett V; Fersht AR
Nat Struct Biol; 2002 Feb; 9(2):112-6. PubMed ID: 11753432
[TBL] [Abstract][Full Text] [Related]
15. Identification of multiple amyloidogenic sequences in laminin-1.
Kasai S; Urushibata S; Hozumi K; Yokoyama F; Ichikawa N; Kadoya Y; Nishi N; Watanabe N; Yamada Y; Nomizu M
Biochemistry; 2007 Apr; 46(13):3966-74. PubMed ID: 17348688
[TBL] [Abstract][Full Text] [Related]
16. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?
Abedini A; Raleigh DP
J Mol Biol; 2006 Jan; 355(2):274-81. PubMed ID: 16303136
[TBL] [Abstract][Full Text] [Related]
17. 1-Palmitoyl-2-(9'-oxononanoyl)-sn-glycero-3-phosphocholine, an oxidized phospholipid, accelerates Finnish type familial gelsolin amyloidosis in vitro.
Mahalka AK; Maury CP; Kinnunen PK
Biochemistry; 2011 Jun; 50(22):4877-89. PubMed ID: 21545139
[TBL] [Abstract][Full Text] [Related]
18. Peptides corresponding to gelsolin derived amyloid of the finnish type (AGelFIN) adopt two distinct forms in solution of which only one can polymerize into amyloid fibrils and form complexes with apoE.
Fadika GO; Baumann M
Amyloid; 2002 Jun; 9(2):75-82. PubMed ID: 12440479
[TBL] [Abstract][Full Text] [Related]
19. Conservation and amyloid formation: a study of the gelsolin-like family.
Benyamini H; Gunasekaran K; Wolfson H; Nussinov R
Proteins; 2003 May; 51(2):266-82. PubMed ID: 12660995
[TBL] [Abstract][Full Text] [Related]
20. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice.
Kirschner DA; Elliott-Bryant R; Szumowski KE; Gonnerman WA; Kindy MS; Sipe JD; Cathcart ES
J Struct Biol; 1998 Dec; 124(1):88-98. PubMed ID: 9931277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
